Abstract
This article reviews the multidisciplinary social science literature assessing the social consequences of medical treatment for male sexual dysfunction. This literature applies medicalization theory and social constructionist approaches to gender to assert that Euro-American cultural ideals of masculinity and sexuality, as well as ageism and ableism, determine which sexual changes and experiences get defined as “dysfunction” and shape the marketing and use of medical treatments for those changes. These medical responses assuage the suffering of men who become unable to meet cultural ideals for sexuality but in the process make reductive norms for male sexuality seem biologically natural. In addition, the critical social science research suggests that an economic logic underlies the process of redefining diversity and change in men’s sexual function as medical pathology. However, comparative qualitative data on men’s and their sexual partners’ experiences of sexuality and aging across world regions suggest that people do not universally accept the narrow ideals of male sexuality embedded in medical discourse regarding men’s sexual dysfunction. The diversity in people’s sexual desires across the life course and their responses to sexual function change highlight the cultural nature of medical definitions of sexual dysfunction.
Acknowledgments
I am grateful to Sari van Anders for her support as I conceptualized this piece, to the reviewers for their helpful feedback, and to Ajay Nangia and Leonore Tiefer for their insights on earlier versions of this work.
Notes
1 There are also rich literatures on other aspects of men’s sexual and reproductive health that draw on similar theoretical approaches and make similar critiques as those discussed here in reference to the sexual function literature (for a discussion of these similarities, see Inhorn & Wentzell, Citation2011). For example, the critical social science literature on male fertility control and infertility treatment critiques the exclusion of men from research on and policy regarding reproduction and reproductive technologies (Almeling & Waggoner, Citation2013; Culley, Hudson, & Lohan, Citation2013; Daniels, Citation2006; Dudgeon & Inhorn, Citation2003, Citation2004; Greene & Biddlecom, Citation2000; Lohan, Citation2015; Marsiglio, Lohan, & Culley, Citation2013; Wentzell & Inhorn, Citation2014). It offers a rich body of qualitative research redressing this issue by identifying men’s context-specific experiences of assisted reproduction technologies and the specifics of local cultural understandings of the relationships between masculinity and reproduction, as well as how these are influenced by factors like law, economics, and religion (e.g., Açıksöz, Citation2015; Adrian, Citation2010; Almeling, Citation2011; Barnes, Citation2014; Bledsoe, Lerner, & Guyer, Citation2000; Carmeli & Birenbaum-Carmeli, Citation1994; Gannon, Glover, & Abel, Citation2004; Gürtin, Citation2015; Herrera, Citation2013; Hinton & Miller, Citation2013; Inhorn, Citation1996, Citation2003, Citation2012; Inhorn, Tjornhoj-Thomsen, Goldberg, & Mosegaard, Citation2009; Locock & Alexander, Citation2006; Mohr, Citation2014; Moore, Citation2008; Reed, Citation2005; Throsby & Gill, Citation2004; Webb & Daniluk, Citation1999; Wu, Citation2011). This literature also calls for attention to how culturally specific ideas of masculinity shape men’s uses of contraception (Adongo et al., Citation2014; Amor et al., Citation2008; Cragun & Sumerau, Citation2015; Gutmann, Citation2007; Pomales, Citation2013; Shropshire, Citation2014; Terry, Citation2014; Terry & Braun, Citation2011a, Citation2011b, Citation2011c), as well as scientific efforts to develop male contraceptives (Oudshoorn, Citation2003).
2 A robust body of critical research has identified the ways that women’s unhappiness with their sex lives, or fears that their sexual function is “abnormal,” are rooted in poor sex education (which fails to challenge the idea that orgasm from penetration is the “normal” and even a common way to climax), interpersonal problems related to gender inequality, and deliberate disease mongering which casts the resulting issues as “female sexual dysfunction” to be treated medically rather than socially (Bancroft, Citation2002; Bedor, Citation2016; Cacchioni, Citation2007; Drew, Citation2003; Farrell & Cacchioni, Citation2012; Fishman, Citation2004; Fishman & Mamo, Citation2002; Hartley, Citation2003, Citation2006; Hartley & Tiefer, Citation2003; Jutel, Citation2010; Labuski, Citation2013, Citation2015; Lavie-Ajayi, Citation2005; Moynihan, Citation2003, Citation2010; Nicolson & Burr, Citation2003; Potts, Citation2008; Tiefer, Citation2003). This work is interlinked with activist campaigns that lobby against government approval of drugs which treat these social problems (Kaschak & Tiefer, Citation2001; Moynihan, Citation2014; Tiefer, Citation2002a, Citation2002b, Citation2006)—a process documented in the film Orgasm, Inc. (Canner, Citation2008; Canner, Benello, Ettinger, Helfand, & Weiss, Citation2009), and medical analysis arguing that U.S. Food and Drug Administration approval campaigns are based on marketing rather than demonstrations of efficacy (Jaspers et al., Citation2016; Woloshin & Schwartz, Citation2016). A similar critical literature is also emerging on “cosmetogynecology,” in which women undergo cosmetic surgery to remove parts of the vulva considered unaesthetic and thus meet increasingly narrow genital beauty norms (Braun, Citation2005, Citation2009, Citation2010; Liao, Taghinejadi, & Creighton, Citation2012; Tiefer, Citation2008a).
3 Discussions of “sexual health” in general reflect this same history of medicalization as men’s sexual function change. The concept of “sexual health” similarly isolates sexuality from interpersonal, economic, and political context, while casting culturally specific ideas of how sexuality and gender should be as biological universals (Giami, Citation2002; Segal, Citation2012).
4 Anthropologist Margaret Lock proposed the idea of “local biologies” to understand this concept, in her study of quantitative differences in menopause symptoms reported by North American and Japanese women, which she relates to a combination of different cultural expectations regarding symptomology and different body practices, such as diet (Lock, Citation1993; Lock & Kaufert, Citation2001).
Inhorn, M. C., & Wentzell, E. (2011). Embodying emergent masculinities: Reproductive and sexual health technologies in the Middle East and Mexico. American Ethnologist, 38, 801–815. doi:10.1111/j.1548-1425.2011.01338.x Almeling, R., & Waggoner, M. R. (2013). More and less than equal: How men factor in the reproductive equation. Gender and Society, 27, 821–842. doi:10.1177/0891243213484510 Culley, L., Hudson, N., & Lohan, M. (2013). Where are all the men? The marginalization of men in social scientific research on infertility. Reproductive Biomedicine Online, 27, 225–235. doi:10.1016/j.rbmo.2013.06.009 Daniels, C. R. (2006). Exposing men: The science and politics of male reproduction. Cambridge, UK: Oxford University Press. Dudgeon, M. R., & Inhorn, M. C. (2003). Gender, masculinity, and reproduction: Anthropological perspectives. International Journal of Men’s Health, 2, 31–56. doi:10.3149/jmh.0201.31 Dudgeon, M. R., & Inhorn, M. C. (2004). Men’s influences on women’s reproductive health: Medical anthropological perspectives. Social Science and Medicine, 59, 1379–1395. doi:10.1016/j.socscimed.2003.11.035 Greene, M. E., & Biddlecom, A. E. (2000). Absent and problematic men: Demographic accounts of male reproductive roles. Population and Development Review, 26, 81–115. doi:10.1111/padr.2000.26.issue-1 Lohan, M. (2015). Advancing research on men and reproduction. International Journal of Men’s Health, 14, 214. doi:10.3149/jmh.1403.214 Marsiglio, W., Lohan, M., & Culley, L. (2013). Framing men’s experience in the procreative realm. Journal of Family Issues, 34, 1011–1036. doi:10.1177/0192513X13484260 Wentzell, E., & Inhorn, M. C. (2014). Reconceiving masculinity and “men as partners” for ICPD Beyond 2014: Insights from a Mexican HPV study. Global Public Health, 9, 691–705. doi:10.1080/17441692.2014.917690 Açıksöz, S. C. (2015). In vitro nationalism: Masculinity, disability, and assisted reproduction in war-torn Turkey. In G. Ozyegin (Ed.), Gender and sexuality in Muslim cultures (pp. 19–36). Burlington, VT: Ashgate. Adrian, S. W. (2010). Sperm stories: Policies and practices of sperm banking in Denmark and Sweden. European Journal of Women’s Studies, 17, 393–411. doi:10.1177/1350506810378078 Almeling, R. (2011). Sex cells: The medical market for eggs and sperm. Berkeley: University of California Press. Barnes, L. W. (2014). Conceiving masculinity: Male infertility, medicine, and identity. Philadelphia, PA: Temple University Press. Bledsoe, C., Lerner, S., & Guyer, J. (Eds.) (2000). Fertility and the male life-cycle in the era of fertility decline. Oxford, UK: Oxford University Press. Carmeli, Y. S., & Birenbaum-Carmeli, D. (1994). The predicament of masculinity: Towards understanding the male’s experience of infertility treatments. Sex Roles, 30, 663–677. doi:10.1007/BF01544669 Gannon, K., Glover, L., & Abel, P. (2004). Masculinity, infertility, stigma, and media reports. Social Science and Medicine, 59, 1169–1175. doi:10.1016/j.socscimed.2004.01.015 Gürtin, Z. B. (2015). Assumed, promised, forbidden: Infertility, IVF, and fatherhood in Turkey. In M. C. Inhorn, W. Chavkin, & J.-A. Navarro (Eds.), Globalized fatherhood (pp. 223–242). New York, NY: Berghann Books. Herrera, F. (2013). “Men always adopt”: Infertility and reproduction from a male perspective. Journal of Family Issues, 34, 1059–1080. doi:10.1177/0192513X13484278 Hinton, L., & Miller, T. (2013). Mapping men’s anticipations and experiences in the reproductive realm: (In)fertility journeys. Reproductive Biomedicine Online, 27, 244–252. doi:10.1016/j.rbmo.2013.06.008 Inhorn, M. C. (1996). Infertility and patriarchy: The cultural politics of gender and family life in Egypt. Philadelphia, PA: University of Pennsylvania Press. Inhorn, M. C. (2003). Local babies, global science: Gender, religion, and in vitro fertilization in Egypt. New York, NY: Routledge. Inhorn, M. C. (2012). The new Arab man: Emergent masculinities, technologies, and Islam in the Middle East. Princeton, NJ: Princeton University Press. Inhorn, M. C., Tjornhoj-Thomsen, T., Goldberg, H., & Mosegaard, M. L. C. (Eds.). (2009). Reconceiving the second sex: Men, masculinity, and reproduction. New York, NY: Berghann Books. Locock, L., & Alexander, J. (2006). “Just a bystander”? Men’s place in the process of fetal screening and diagnosis. Social Science and Medicine, 62, 1349–1359. doi:10.1016/j.socscimed.2005.08.011 Mohr, S. (2014). Beyond motivation: On what it means to be a sperm donor in Denmark. Anthropology and Medicine, 21, 162–173. doi:10.1080/13648470.2014.914806 Moore, L. J. (2008). Sperm counts: Overcome by man’s most precious fluid. New York, NY: New York University Press. Reed, R. K. (2005). Birthing fathers: The transformation of men in American rites of birth. New Brunswick, NJ: Rutgers University Press. Throsby, K., & Gill, R. (2004). “It’s different for men”: Masculinity and IVF. Men and Masculinities, 6, 330–348. doi:10.1177/1097184X03260958 Webb, R. E., & Daniluk, J. C. (1999). The end of the line infertile men’s experiences of being unable to produce a child. Men and Masculinities, 2, 6–25. doi:10.1177/1097184X99002001002 Wu, C. L. (2011). Managing multiple masculinities in donor insemination: Doctors configuring infertile men and sperm donors in Taiwan. Sociology of Health and Illness, 33, 96–113. doi:10.1111/j.1467-9566.2010.01274.x Adongo, P. B., Tapsoba, P., Phillips, J. F., Tabong, P. T.-N., Stone, A., & Kuffour, E. (2014). “If you do vasectomy and come back here weak, I will divorce you”: A qualitative study of community perceptions about vasectomy in Southern Ghana. BMC International Health and Human Rights, 14. doi:10.1186/1472-698X-14-16 Amor, C., Rogstad, K. E., Tindall, C., Moore, K. T. H., Giles, D., & Harvey, P. (2008). Men’s experiences of vasectomy: A grounded theory study. Sexual and Relationship Therapy, 23, 235–245. doi:10.1080/14681990802206762 Cragun, R. T., & Sumerau, J. E. (2015). Losing manhood like a man: A collaborative autoethnographic examination of masculinities and the experience of a vasectomy. Men and Masculinities. Advance online publication. doi:10.1177/1097184X15612516 Gutmann, M. C. (2007). Fixing men: Sex, birth control, and AIDS in Mexico. Berkeley, CA: University of California Press. Pomales, T. O. (2013). Men’s narratives of vasectomy. Medical Anthropology Quarterly, 27, 23–42. doi:10.1111/maq.12014 Shropshire, S. (2014). What’sa guy to do? Contraceptive responsibility, confronting masculinity, and the history of vasectomy in Canada. Canadian Bulletin of Medical History/Bulletin Canadien D’histoire De La Médecine, 31, 161–182. Terry, G. (2014). “Suddenly, bang, one day there’s commitment with a woman”: Men, vasectomy, and the life course. Human Fertility, 17, 197–202. doi:10.3109/14647273.2014.949311 Terry, G., & Braun, V. (2011a). “I’m committed to her and the family”: Positive accounts of vasectomy among New Zealand men. Journal of Reproductive and Infant Psychology, 29, 276–291. doi:10.1080/02646838.2011.592976 Terry, G., & Braun, V. (2011b). “It’s kind of me taking responsibility for these things”: Men, vasectomy, and “contraceptive economies.” Feminism and Psychology, 21, 477–495. doi:10.1177/0959353511419814 Terry, G., & Braun, V. (2011c). Sticking my finger up at evolution: Unconventionality, selfishness, and choice in the talk of men who have had “preemptive” vasectomies. Men and Masculinities., 15, 207–229. doi:10.1177/1097184X11430126 Oudshoorn, N. (2003). The male pill: A biography of a technology in the making. Durham, NC: Duke University Press. Bancroft, J. (2002). The medicalization of female sexual dysfunction: The need for caution. Archives of Sexual Behavior, 31, 451–455. doi:10.1023/A:1019800426980 Bedor, E. (2016). It’s not you, it’s your (old) vagina: Osphena’s articulation of sexual dysfunction. Sexuality and Culture, 20, 38–55. doi:10.1007/s12119-015-9308-z Cacchioni, T. (2007). Heterosexuality and “the labour of love”: A contribution to recent debates on female sexual dysfunction. Sexualities, 10, 299–320. doi:10.1177/1363460707078320 Drew, J. (2003). The myth of female sexual dysfunction and its medicalization. Sexualities, Evolution, and Gender, 5, 89–96. doi:10.1080/14616660310001632563 Farrell, J., & Cacchioni, T. (2012). The medicalization of women’s sexual pain. Journal of Sex Research, 49, 328–336. doi:10.1080/00224499.2012.688227 Fishman, J. R. (2004). Manufacturing desire: The commodification of female sexual dysfunction. Social Studies of Science, 34, 187–218. doi:10.1177/0306312704043028 Fishman, J. R., & Mamo, L. (2002). What’s in a disorder: A cultural analysis of medical and pharmaceutical constructions of male and female sexual dysfunction. Women and Therapy, 24, 179–193. doi:10.1300/J015v24n01_20 Hartley, H. (2003). “Big Pharma” in our bedrooms: An analysis of the medicalization of women’s sexual problems. Advances in Gender Research, 7, 89–129. doi:10.1016/S1529-2126(03)07004-8 Hartley, H. (2006). The “pinking” of Viagra culture: Drug industry efforts to create and repackage sex drugs for women. Sexualities, 9, 363–378. doi:10.1177/1363460706065058 Hartley, H., & Tiefer, L. (2003). Taking a biological turn: The push for a “female Viagra” and the medicalization of women’s sexual problems. Women’s Studies Quarterly, 31, 42–54. Jutel, A. (2010). Framing disease: The example of female hypoactive sexual desire disorder. Social Science and Medicine, 70, 1084–1090. doi:10.1016/j.socscimed.2009.11.040 Labuski, C. (2013). Vulnerable vulvas: Female genital integrity in health and dis-ease. Feminist Studies, 39, 248–276. Labuski, C. (2015). It hurts down there: The bodily imaginaries of female genital pain. Albany: State University of New York Press. Lavie-Ajayi, M. (2005). “Because all real women do”: The construction and deconstruction of “female orgasmic disorder.” Sexualities, Evolution, and Gender, 7, 57–72. doi:10.1080/14616660500123664 Moynihan, R. (2003). The making of a disease: Female sexual dysfunction. British Medical Journal, 326, 45–47. doi:10.1136/bmj.326.7379.45 Moynihan, R. (2010). Merging of marketing and medical science: Female sexual dysfunction. British Medical Journal, 341, c5050. doi:10.1136/bmj.c5050 Nicolson, P., & Burr, J. (2003). What is “normal” about women’s (hetero)sexual desire and orgasm? A report of an in-depth interview study. Social Science and Medicine, 57, 1735–1745. doi:10.1016/S0277-9536(03)00012-1 Potts, A. (2008). The female sexual dysfunction debate: Different “problems,” new drugs—More pressures? In P. Moss & K. Teghtsoonian (Eds.), Contesting illness: Processes and practices (pp. 259–280). Toronto, Canada: University of Toronto Press. Tiefer, L. (2003). Female sexual dysfunction (FSD): Witnessing social construction in action. Sexualities, Evolution, and Gender, 5, 33–36. doi:10.1080/14616660310001594962 Kaschak, E., & Tiefer, L. (Eds.). (2001). A new view of women’s sexual problems. Binghamton, NY: Haworth Press. Moynihan, R. (2014). Evening the score on sex drugs: Feminist movement or marketing masquerade? British Medical Journal, 349, g6246. doi:10.1136/bmj.g6246 Tiefer, L. (2002a). Arriving at a “new view” of women’s sexual problems: Background, theory, and activism. Women and Therapy, 24, 63–98. doi:10.1300/J015v24n01_12 Tiefer, L. (2002b). Beyond the medical model of women’s sexual problems: A campaign to resist the promotion of “female sexual dysfunction.” Sexual and Relationship Therapy, 17, 127–135. doi:10.1080/14681990220121248 Tiefer, L. (2006). Female sexual dysfunction: A case study of disease mongering and activist resistance. Public Library of Science Medicine, 3, 436–440. doi:10.1371/journal.pmed.0030178 Canner, E. (2008). Sex, lies, and pharmaceuticals: The making of an investigative documentary about female sexual dysfunction. Feminism and Psychology, 18, 488–494. doi:10.1177/0959353508095531 Canner, E. (Director), Benello, J. P. (Producer), Ettinger, W. (Producer), Helfand, J. (Producer), & Weiss, M. N. (Producer). (2009). Orgasm Inc: The strange science of female pleasure [Motion picture]. United States: Astrea Media. Jaspers, L., Feys, F., Bramer, W. M., Franco, O. H., Leusink, P., & Laan, E. M. (2016). Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: A systematic review and meta-analysis. Journal of the American Medical Association Internal Medicine, 176, 453–462. doi:10.1001/jamainternmed.2015.8565 Woloshin, S., & Schwartz, L. M. (2016). U.S. Food and Drug Administration approval of flibanserin: Even the score does not add up. Journal of the American Medical Association Internal Medicine., 176, 439–442. doi:10.1001/jamainternmed.2016.0073 Braun, V. (2005). In search of (better) sexual pleasure: Female genital “cosmetic” surgery. Sexualities, 8, 407–424. doi:10.1177/1363460705056625 Braun, V. (2009). Selling the “perfect” vulva. In C. J. Heyes & M. Jones (Eds.), Cosmetic surgery: A feminist primer (pp. 133–149). Burlington, VT: Ashgate. Braun, V. (2010). Female genital cosmetic surgery: A critical review of current knowledge and contemporary debates. Journal of Women’s Health, 19, 1393–1407. doi:10.1089/jwh.2009.1728 Liao, L.-M., Taghinejadi, N., & Creighton, S. M. (2012). An analysis of the content and clinical implications of online advertisements for female genital cosmetic surgery. British Medical Journal Open, 2, e001908. doi:10.1136/bmjopen-2012-001908 Tiefer, L. (2008a). Female genital cosmetic surgery: Freakish or inevitable? Analysis from medical marketing, bioethics, and feminist theory. Feminism and Psychology, 18, 466–479. doi:10.1177/0959353508095529 Giami, A. (2002). Sexual health: The emergence, development, and diversity of a concept. Annual Review of Sex Research, 13, 1–35. doi:10.1080/10532528.2002.10559801 Segal, J. Z. (2012). The sexualization of the medical. Journal of Sex Research, 49, 369–378. doi:10.1080/00224499.2011.653608 Lock, M. (1993). Encounters with aging: Mythologies of menopause in Japan and North America. Berkeley: University of California Press. Lock, M., & Kaufert, P. (2001). Menopause, local biologies, and cultures of aging. American Journal of Human Biology, 13, 494–504. doi:10.1002/(ISSN)1520-6300